Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer
Xiaochao Tan, … , William K. Russell, Jonathan M. Kurie
Xiaochao Tan, … , William K. Russell, Jonathan M. Kurie
Published April 25, 2024
Citation Information: J Clin Invest. 2024;134(12):e176355. https://doi.org/10.1172/JCI176355.
View: Text | PDF
Research Article Cell biology Oncology

Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer

  • Text
  • PDF
Abstract

Cancer cells exhibit heightened secretory states that drive tumor progression. Here, we identified a chromosome 3q amplicon that serves as a platform for secretory regulation in cancer. The 3q amplicon encodes multiple Golgi-resident proteins, including the scaffold Golgi integral membrane protein 4 (GOLIM4) and the ion channel ATPase secretory pathway Ca2+ transporting 1 (ATP2C1). We show that GOLIM4 recruited ATP2C1 and Golgi phosphoprotein 3 (GOLPH3) to coordinate Ca2+-dependent cargo loading, Golgi membrane bending, and vesicle scission. GOLIM4 depletion disrupted the protein complex, resulting in a secretory blockade that inhibited the progression of 3q-amplified malignancies. In addition to its role as a scaffold, GOLIM4 maintained intracellular manganese (Mn) homeostasis by binding excess Mn in the Golgi lumen, which initiated the routing of Mn-bound GOLIM4 to lysosomes for degradation. We show that Mn treatment inhibited the progression of multiple types of 3q-amplified malignancies by degrading GOLIM4, resulting in a secretory blockade that interrupted prosurvival autocrine loops and attenuated prometastatic processes in the tumor microenvironment. As it potentially underlies the selective activity of Mn against 3q-amplified malignancies, ATP2C1 coamplification increased Mn influx into the Golgi lumen, resulting in a more rapid degradation of GOLIM4. These findings show that functional cooperativity between coamplified genes underlies heightened secretion and a targetable secretory addiction in 3q-amplified malignancies.

Authors

Xiaochao Tan, Shike Wang, Guan-Yu Xiao, Chao Wu, Xin Liu, Biyao Zhou, Yu Jiang, Dzifa Y. Duose, Yuanxin Xi, Jing Wang, Kunika Gupta, Apar Pataer, Jack A. Roth, Michael P. Kim, Fengju Chen, Chad J. Creighton, William K. Russell, Jonathan M. Kurie

×

Figure 4

Functional cooperativity between 3q-amplified genes.

Options: View larger image (or click on image) Download as PowerPoint
Functional cooperativity between 3q-amplified genes.
(A) TurboID-GOLIM4 ...
(A) TurboID-GOLIM4 fusion construct (schema, top) localizes in the Golgi (confocal micrographs, bottom). H1299 cells were transfected with TurboID-GOLIM4 and costained with anti-Flag, anti-GM130, and DAPI (blue). Shown are single-channel and merged images. Scale bar: 50 μm. (B) Volcano plot of GOLIM4-associated proteins identified by TurboID-based proximity ligation assays. Results for each protein identified (data points) are expressed as a log2 ratio (GOLIM4/CTL, x axis; P value, y axis). (C) IP/WB confirmation of ATP2C1 as a GOLIM4-associated protein in H1299 cells. (D) Confocal micrographs of endogenous ATP2C1 and GOLIM4 in H1299 cells. Cells were treated with nocodazole to disperse the Golgi. Line plot (under images) assesses colocalization of GOLIM4 and ATP2C1. Shown are the signal intensities (y axis) and distances from the plasma membrane (x axis). (E) Gene copy numbers (rows) in tumors (columns). HNSC, HN squamous cell carcinoma. P <0.001, significant co-occurrence, by 1-sided Fisher’s exact test. (F) Correlations between ATP2C1 mRNA levels and gene copy numbers in tumors (data points). Diploid, n = 109; gain, n = 311; amplification, n = 48. (G) Pearson’s correlation between GOLIM4 and ATPC1 mRNA levels in tumors (data points). (H–J) WB analysis of secreted protein levels in CM samples and cell lysates. H1299 cells were treated with a Ca2+ chelator (H) or transfected with siRNAs against ATP2C1 (I) or Cab45 (J). (K) Number of APP+ vesicles in H1299 cells transfected with indicated siRNAs. (L) Relative soft agar colony numbers generated by parental and GOLIM4-KO (G4KO) H1299 cells following treatment with CM samples from siRNA-transfected H1299 cells. (M) Boyden chamber assays to quantify HUVEC and CAF recruitment by CM samples from siRNA-transfected H1299 cells. (N) qRT-PCR confirmation of target gene depletion by ATP2C1 shRNAs in H1299 cells. (O and P) Orthotopic tumor size (O) and distant metastases (P) per mouse (data points) generated by H1299 transfectants in N. (Q) WB confirmation of ATP2C1 reconstitution in ATP2C1-KO cells by WT or D350A-mutant ATP2C1. Vec, empty vector. (R and S) Soft agar colony formation assay (R) and Boyden chamber migration assay (S) on cells generated in Q. Data indicate the mean ± SD from a single experiment incorporating biological replicate samples (n = 3, unless otherwise indicated) and are representative of at least 2 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, by 1-way ANOVA (F, K–P, R, and S).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts